Search results
Results from the WOW.Com Content Network
Triamcinolone acetonide is also used in veterinary medicine as an ingredient in topical ointments and in topical sprays for control of pruritus in dogs. [28] A series of injections with triamcinolone acetonide or another corticosteroid may reduce keloid size and irritation. It is used as a preinductor and/or inductor of birth in cows.
Triamcinolone is a glucocorticoid used to treat certain skin diseases, allergies, and rheumatic disorders among others. [6] It is also used to prevent worsening of asthma and chronic obstructive pulmonary disease (COPD). [6] It can be taken in various ways including by mouth, injection into a muscle, and inhalation. [6]
Supratarsal injection is an ocular route of drug administration. It is used to administer a medication to the Tarsus of the eyelid . Supratarsal injection of corticosteroids , such as hydrocortisone , triamcinolone acetonide and dexametasone , [ 1 ] is indicated in the treatment of refractory or recalcitrant vernal keratoconjunctivitis (VKC ...
If you can afford surgery, a disease like IVDD can be cured. If you cannot afford the diagnostics at this time, my suggestion would be to treat this like a case of arthritis with some impingement ...
For non-responsive cases, potential treatments include topical ciclosporin A, [8] vitamin A, [9] autologous serum [10] and injections of triamcinolone. [11] Surgical treatment options include thermocauterization of the bulbar conjunctiva [12] and conjunctival resection, [13] typically under rose bengal (RB) staining to visualize affected areas. [7]
Triamcinolone hexacetonide (brand name Aristospan; also known as triamcinolone acetonide 21-tebutate) is a synthetic glucocorticoid corticosteroid. [ 3 ] [ 4 ] [ 5 ] It is on the World Health Organization's List of Essential Medicines .
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
The number of injections tripled to 15,000 in 2002 when triamcinolone injections were first used to treat diabetic macular oedema. [2] [3] This use continued to drive an increase to 83,000 injections in 2004. [2] In 2005 bevacizumab and ranibizumab intravitreal injections for the treatment of wet-AMD caused a rise in injections to 252,000. [2]